Involvement of the 90-kDa Heat Shock Protein (Hsp-90) in CB2 Cannabinoid Receptor-Mediated Cell Migration: A New Role of Hsp-90 in Migration Signaling of a G Protein-Coupled Receptor

The endocannabinoid 2-arachidonoylglycerol (2-AG) enhances cell migration through the CB2 cannabinoid receptor. In this study, using an immunoprecipitation and mass spectrometry-based proteomic approach, we first identified the 90-kDa heat shock protein (Hsp90), a chaperone protein with novel signaling functions, as a CB2-interacting protein. The CB2/Hsp90 interaction was confirmed in human embryonic kidney 293 cells expressing transfected CB2 and in differentiated HL-60 cells expressing endogenous CB2, by coimmunoprecipitation and Western blot experiments, as well as by treatment with geldanamycin (GA), a specific Hsp90 inhibitor. Disruption of the CB2/Hsp90 interaction by treatment with GA or reducing Hsp90 levels with specific short interfering RNAs markedly inhibited 2-AG-induced cell migration, demonstrating that Hsp90 is crucial for 2-AG-induced cell migration. 2-AG treatment resulted in a CB2-mediated stimulation of Rac1 activity, and treatment with GA blocked 2AG-induced activation of Rac1. It is noteworthy that expression of the dominant-negative form of Rac1 reduced 2-AG-induced cell migration. These data demonstrate that 2-AG-induced activation of Rac1 is essential for 2-AG-induced cell migration, and the CB2/Hsp90 interaction is needed for 2-AG-induced activation of Rac1. Furthermore, 2-AG-induced Rac1 activation was sensitive to pertussis toxin treatment, hence involving Gi proteins. In addition, treatment with GA significantly inhibited the CB2/Gαi2 interaction. As a whole, our data indicate that Hsp90 may serve as scaffold to keep the CB2 receptor and its signaling components, including Gαi2, in proximity, thus facilitating CB2-mediated signaling to cell migration through the Gi-Rac1 pathway. By demonstrating that Hsp90 is essential for CB2-mediated signaling to cell migration, this study reveals a novel role of Hsp90 in the signaling events mediated by a G protein-coupled receptor.

[1]  Jian Cai,et al.  Biochemical and mass spectrometric characterization of the human CB2 cannabinoid receptor expressed in Pichia pastoris--importance of correct processing of the N-terminus. , 2007, Protein expression and purification.

[2]  M. Glogauer,et al.  Rac1 links leading edge and uropod events through Rho and myosin activation during chemotaxis. , 2006, Blood.

[3]  C. Lunn,et al.  Targeting the CB2 receptor for immune modulation , 2006, Expert opinion on therapeutic targets.

[4]  K. Jacobson,et al.  Keynote review: allosterism in membrane receptors. , 2006, Drug discovery today.

[5]  A. Kungl,et al.  A proteomic snapshot of the human heat shock protein 90 interactome , 2005, FEBS letters.

[6]  P. Sexton,et al.  G‐Protein‐coupled receptor–protein interactions: Basis for new concepts on receptor structure and function , 2005, Clinical and experimental pharmacology & physiology.

[7]  P. Marin,et al.  GPCR-interacting proteins (GIPs): nature and functions. , 2004, Biochemical Society transactions.

[8]  K. Waku,et al.  2‐Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL‐1 human eosinophilic leukemia cells and human peripheral blood eosinophils , 2004, Journal of leukocyte biology.

[9]  B. Löwenberg,et al.  The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner. , 2004, Blood.

[10]  Krister Wennerberg,et al.  Rho and Rac Take Center Stage , 2004, Cell.

[11]  K. Hoffmann,et al.  Development of the Optokinetic Response in Macaques , 2003, Annals of the New York Academy of Sciences.

[12]  Jingsong Xu,et al.  Divergent Signals and Cytoskeletal Assemblies Regulate Self-Organizing Polarity in Neutrophils , 2003, Cell.

[13]  K. Waku,et al.  2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism* , 2003, Journal of Biological Chemistry.

[14]  R. Delwel,et al.  Identification, Characterization, and Function of a Novel Oncogene , 2003, Annals of the New York Academy of Sciences.

[15]  Jian Cai,et al.  Expression of CB2 cannabinoid receptor in Pichia pastoris. , 2002, Protein expression and purification.

[16]  S. Martinelli,et al.  Differentiated HL-60 cells are a valid model system for the analysis of human neutrophil migration and chemotaxis. , 2002, The international journal of biochemistry & cell biology.

[17]  B. Löwenberg,et al.  Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. , 2002, Blood.

[18]  L. Limbird,et al.  G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. , 2002, Cellular signalling.

[19]  A. Ridley,et al.  Rho family proteins: coordinating cell responses. , 2001, Trends in cell biology.

[20]  V. Mahajan,et al.  Thrombin Receptor Signaling to Cytoskeleton Requires Hsp90* , 2001, The Journal of Biological Chemistry.

[21]  K. Waku,et al.  2-Arachidonoylglycerol and the cannabinoid receptors. , 2000, Chemistry and physics of lipids.

[22]  Patricia H. Reggio,et al.  The Difference between the CB1 and CB2Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2 , 1999 .

[23]  É. Mezey,et al.  Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat , 1997, Neuroscience.

[24]  Neal Rosen,et al.  Crystal Structure of an Hsp90–Geldanamycin Complex: Targeting of a Protein Chaperone by an Antitumor Agent , 1997, Cell.

[25]  T. Bonner,et al.  A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. , 1996, Molecular pharmacology.

[26]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[27]  K. Yamamoto,et al.  Hold 'em and fold 'em: chaperones and signal transduction. , 1995, Science.

[28]  C. Zuker,et al.  Protein folding and the regulation of signaling pathways , 1994, Cell.

[29]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[30]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[31]  N. E. Buckley,et al.  Experimental methods to study the role of the peripheral cannabinoid receptor in immune function. , 2006, Methods in molecular medicine.

[32]  R. Mechoulam,et al.  The chemistry of endocannabinoids. , 2006, Journal of endocrinological investigation.

[33]  M. Gaestel,et al.  Molecular chaperones in signal transduction. , 2006, Handbook of experimental pharmacology.

[34]  R. Pertwee,et al.  Pharmacological actions of cannabinoids. , 2005, Handbook of experimental pharmacology.

[35]  A. Hall,et al.  Cell migration: Rho GTPases lead the way. , 2004, Developmental biology.

[36]  K. Waku,et al.  New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation. , 2004, Journal of pharmacological sciences.

[37]  D. Hurst,et al.  The difference between the CB(1) and CB(2) cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN55212-2 for CB(2). , 1999, Molecular pharmacology.

[38]  R. Pertwee.  Pharmacology of cannabinoid CB1 and CB2 receptors. , 1997, Pharmacology & therapeutics.

[39]  W. Pratt.  The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. , 1997, Annual review of pharmacology and toxicology.

[40]  T. Sugiura,et al.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.

[41]  T. Katada,et al.  Bacterial toxins as probe for receptor-Gi coupling. , 1990, Advances in second messenger and phosphoprotein research.